tiprankstipranks
Advertisement
Advertisement

Single Quantum Showcases Integrated High-Sensitivity Imaging at Focus on Microscopy 2026

Single Quantum Showcases Integrated High-Sensitivity Imaging at Focus on Microscopy 2026

A LinkedIn post from Single Quantum highlights the company’s live participation at the Focus on Microscopy 2026 conference, where it is demonstrating high‑sensitivity imaging capabilities. The post emphasizes an integrated setup combining a PicoQuant confocal microscope with Single Quantum’s R12 superconducting nanowire single-photon detector (SNSPD) system for fluorescence imaging across visible, NIR, and SWIR ranges.

Claim 30% Off TipRanks

According to the post, technical features on display include high detection efficiency, ultra‑low dark counts, and timing resolution below 15 picoseconds for time‑resolved microscopy techniques such as FLIM and TRPL. The company also points to deep‑tissue imaging capabilities in biological samples using optical windows around 1,000 nm, 1,400 nm, and 1,900 nm, suggesting a focus on advanced biomedical and life‑science applications.

For investors, the post suggests continued investment in application‑driven integration of Single Quantum’s SNSPD technology with established microscopy platforms. This focus may support revenue growth opportunities in research labs, biomedical imaging, and photonics instrumentation, where high‑performance detection is critical and switching costs can be significant.

The collaboration and co‑demonstration with PicoQuant may indicate efforts to deepen ecosystem partnerships and improve system‑level adoption rather than selling standalone detectors. If these demonstrations translate into design wins or preferred‑vendor status with microscopy and instrumentation OEMs, Single Quantum could strengthen its competitive positioning in the high‑end imaging and quantum‑photonics markets.

The emphasis on NIR/SWIR fluorescence imaging and deep‑tissue capabilities aligns with growing demand for non‑invasive diagnostics and advanced life‑science research tools. This positioning could help the company tap into expanding budgets in biomedical imaging and quantum‑enabled sensing, although the post does not provide information on pricing, orders, or specific commercial contracts associated with the FOM 2026 activities.

Disclaimer & DisclosureReport an Issue

1